Literature DB >> 10082117

Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.

R Zamarchi1, S Indraccolo, S Minuzzo, V Coppola, A Gringeri, E Santagostino, E Vicenzi, G De Silvestro, R Biagiotti, C Baldassarre, L Chieco-Bianchi, A Amadori.   

Abstract

The aim of this study was to assess the frequency of a truncated allele of the CCR-5 gene (delta32) in Italy, and address its possible role in parenteral HIV transmission, as well as its influence in HIV-associated disease progression. In 371 unrelated seronegative healthy blood donors the delta32 allele frequency was 0.047; this figure was significantly different from those reported in northern America and northern Europe populations. However, delta32 allele frequency in healthy individuals did not differ significantly from that found in 54 seronegative drug users (0.065), 98 seronegative hemophiliacs (0.051), and 81 seropositive hemophiliacs (0.049). Although in seropositive hemophiliacs the wt/delta32 heterozygous genotype was associated with a trend to a slower decline in CD4+ cell counts, its presence did not seem to influence disease progression, as comparable delta32 allele frequency frequencies were found among progressing (0.042) and nonprogressing (0.111) patients. These data do not seem to support a protective role of the delta32 allele in preventing HIV infection through the parenteral route, or in influencing the natural history of the disease in this particular risk category, although the delta32 heterozygous state was associated with lower plasma viremia levels. On the other hand, the finding of non-syncytium-inducing HIV strains in the majority of delta32 heterozygous seropositive patients suggests that its presence could not be a major factor in driving a switch toward more cytopathic, T-tropic HIV strains through selective pressure in coreceptor usage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082117     DOI: 10.1089/088922299311303

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes.

Authors:  R Zamarchi; P Allavena; A Borsetti; L Stievano; V Tosello; N Marcato; G Esposito; V Roni; C Paganin; G Bianchi; F Titti; P Verani; G Gerosa; A Amadori
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1.

Authors:  F A Koning; D Schols; H Schuitemaker
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  The geographic spread of the CCR5 Delta32 HIV-resistance allele.

Authors:  John Novembre; Alison P Galvani; Montgomery Slatkin
Journal:  PLoS Biol       Date:  2005-10-18       Impact factor: 8.029

4.  Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.

Authors:  Enrico M Trecarichi; Mario Tumbarello; Katleen de Gaetano Donati; Enrica Tamburrini; Roberto Cauda; Christina Brahe; Francesco D Tiziano
Journal:  AIDS Res Ther       Date:  2006-09-25       Impact factor: 2.250

5.  Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.

Authors:  Scott A Tenenbaum; Cindy A Morris; Steve S Alexander; Harris E McFerrin; Robert F Garry; Cindy A Leissinger
Journal:  Virol J       Date:  2005-08-17       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.